Month: January 2012

First surgery of implant prosthesis of penis and foto vaporización of prostate laser in the same patient

|

first surgery of implant prosthesis of penis and foto-vaporización of prostate laser in the same patient

is not customary for the realization of the two techniques in one surgical session, which was carried out in HM University Sanchinarro, and avoided surgery and a postoperative longest

-the patient70 years, he suffered from erectile dysfunction for five years and did not respond satisfactorily to inhibitors pharmacological treatments of the phospho-diesterasa, as well as suffer a deterioration of their urinary function because of a benign prostatic hyperplasia which required surgery

-operationconducted by Drs. Rosselló and M. Fernández-Arjona, IMS urologists, it had a duration of 90 minutes and the patient was discharged after 24 hours

-15% of the male population suffers erection problems, not always referring with pharmacological treatment; and oftenfrom the 50 years, they are also presented difficulties in urinary function.

Madrid, January 2012.- The Sexual Medicine Institute (IMS) directed by Dr. Mariano Rosselló, has been carried out in HM University Sanchinarro first surgery which implanted a hydraulic prosthesis of three components to a patient and his prostate laser and endoscopic via foto-vaporización is carried out during the same surgical Act.

The patient, of 70 years, suffered from erectile dysfunction for five years and did not respond satisfactorily to inhibitors pharmacological treatments of phospho-diesterasa. In addition, he suffered a deterioration of their urinary function because of a benign prostatic hyperplasia which required surgery.

The operation, carried out by doctors Rosselló and M. Fernández-Arjona, IMS urologists, lasted 90 minutes and the patient was discharged after 24 hours of the intervention, on a regular basis.

After an intervention of implant prosthesis of penis, the patient can resume intercourse from the fifth week in the majority of cases. The foto-vaporización of the prostate laser is a rapid and effective, minimally invasive procedure that allows the patient to normalize your urinary function a few days of the intervention.

Approximately 15 percent of the male population suffered from erection problems. When oral drugs are not suitable or do not solve the problem, surgery of implant prosthesis of penis is the solution for this pathology.

Often erection problems arising from age 50 may occur also with difficulties in urinary function. In this case, due to the current progress, has been possible to combine two interventions in one, avoiding two surgeries and a postoperative longer.

HM hospitals

HM hospital is composed of several companies that manage different packaging private hospitals including HM University Madrid, HM University Montepríncipe, HM University Torrelodones, HM University Sanchinarro, HM new Bethlehem and Center comprehensive Oncology Clara Campal (CIOCC); all of them of great technical and human skills.

Based on a Decalogue and the Hippocratic oath directed by doctors and with the aim of offering quality medicine, the different centers of HM hospitals have endowed with a cutting edge technology and staff better qualified and more humane.

All HM hospital centres operate in an integrated manner. To do this, there is a corporate structure with centralized services, as well as different management tools. This allows a complementary and synergistic action of structures, services and equipment, with maximum use of the technological and human resources.

Read More

Daiichi Sankyo announces the recruitment of the first patient in the European register on atrial fibrillation PREFER in AF

|

Daiichi Sankyo announces the recruitment of the first patient in the European register on atrial fibrillation PREFER in AF

-More than 5,000 patients with atrial fibrillation from seven European countries, among them Spain, will participate in the registry whose goal is to improve knowledge about one of the main causes of stroke in the continent

January 2012.- Daiichi Sankyo Europe GmbH has announced the recruitment of the first patient of the PREFER registration in AF (PREvention oF thromboembolic events – European Registry in Atrial Fibrillation)(, i.e. Prevention of thrombotic events – European register in fibrillation headset). PREFER in AF is a new approach in the register of cases of atrial fibrillation (AF), since it will cover all kinds of patients, both those who suffer from heart valve types such as the no valve of this condition. The registry will also analyze the impact of new anticoagulant therapy in the prevention of stroke, as well as collect data on the degree of satisfaction of the patients with treatment, have a greater knowledge of how it affects the FA to the quality of life of those who suffer from it and make a more accurate estimation of the economic impact of the disease in Europe.

More than 5,000 patients from seven European countries

In 2010 the World Heart Federation stressed the need to develop new international registrations to help complete knowledge about the handling of the FA. PREFER in AF seeks to respond to this medical necessity through the recruitment of more than 5,000 patients from seven European countries: Spain, Germany, Austria, France, Italy, United Kingdom and Switzerland.

The data extracted from PREFER in AF will be representative at the country level and will provide relevant information from the point of view of health economics, both on the pharmacological treatment of the FA, and complications arising from diseaseincluding admissions, which will allow to estimate the real cost of the FA for European health systems. Dr. José Luis Zamorano, co-Chairman of the Organizing Committee of the PREFER registration in AF and Director of the Institute Cardiovascular of the Hospital Clínico San Carlos Madrid, explains in this respect: “ the potential impact of the FA in the citizens of Europe is very high and it is estimated that the number of people affected will increase in coming years. PREFER in AF will provide great value data on the current approach of the FA and the health and economic impact of this condition, which will indicate where we must go in the treatment of patients with FA ”.

Today, the FA treatment paradigm is changing, so the data arising from the registration will help to establish if the current treatment options are being used properly in clinical practice and contribute to that patients can develop a normal life. In this regard, Dr. Zamorano added: “ the essence of this record is that it focuses on the quality of life of the patient and their level of satisfaction with treatment, both key factors to be considered for an optimal patient care. When patients are satisfied with their treatment, follow him properly and this is especially important in F, a condition associated with high morbidity and mortality ”.

Atrial fibrillation: one of the main causes of stroke

The FA is one of the most frequent causes of hospitalization among the ailments of the corazónii. It is the kind of more common in clinical practice cardiac arrhythmia and affects between 1 and 2 per cent of the general population. The FA is also one of the main causes of ictusii and, moreover, should be noted that the stroke associated with the FA are more severe and have a worse prognosis than those who are not related to the FA.

Daiichi Sankyo, leading company in research and development of innovative therapeutic solutions to cardiovascular diseases, collaborates with the implementation underway PREFER registry in AF. Reinhard Bauer, CEO of Daiichi Sankyo Europe GmbH, explains on the beginning of the registry: “ Daiichi Sankyo is proud to sponsor this valuable observational study of patients with FA. The registry is an example of our continued commitment to the development of medical solutions that will make it possible to improve the treatment of patients with FA, as well as learn more about what the real impact of this disease on patients, physicians and healthcare systems ”.

On PREFER in AF

PREFER in AF is a prospective, multicenter observational record with one year of follow-up. The sample shall be representative of all types of patients with FA without exclusion criteria, and regardless of whether they have anticoagulant therapy or not.

On the headset fibrillation

Atrial fibrillation (AF) is defined as an abnormal heart rhythm. The heart has four cavities, two Atria and two ventricles. The Atria pump blood into the ventricles inside and the ventricles pump blood to the rest of the body by there what must be well coordinated to make the heart pump blood efficiently in every heartbeat.

A normal heart pumped blood with a regular rhythm; the heartbeat may be fast or slow, but the interval between heartbeat is the same. When a person suffers FA produced numerous electrical impulses in the cardiac muscle of the Atria that neutralize the “ timer ” natural which controls the heart. When this occurs, the Atria contract quickly but only partially, and as a result, the heart pumps less efficiently.

For this reason, blood is not properly pumped from the Atria causing it stagnate and clots. These blood clots can break and travel through the bloodstream to the brain where it could cause a stroke.

About Daiichi Sankyo

The Daiichi Sankyo group is dedicated to research and supply of innovative pharmaceutical products, both in mature markets as emerging, they face various medical needs of patients who are not yet covered. The company was created in 2005 through the merger of two Japanese companies of long tradition and Daiichi Sankyo. Daiichi Sankyo is one of world’s 20 leading pharmaceutical companies. In parallel with the maintenance of its drugs for hypertension, Hyperlipidemia, and bacterial infections, the group is focused on the development of treatments for disorders thrombotic, in research in Oncology as well as new therapies in the cardiovascular area and metabolism. On the other hand, the Daiichi Sankyo group has created a “ hybrid business model “, which responds to the diversity of the market and customer seeking to optimize the opportunities for growth in the value chain.

The company’s global headquarters is in Tokyo. Its European base, Daiichi Sankyo Europe, is in Munich and has subsidiaries in 12 European countries as well as a plant of global manufacturing in Pfaffenhofen (Germany).

For more information, please visit www.daiichi-sankyo.es

Read More

EDEPA launches a campaign to raise awareness about chronic low back pain of inflammatory

|

EDEPA launches a campaign to raise awareness about chronic low back pain of inflammatory

-the goal of the campaign is to help patients with back pain to learn about the symptoms, to facilitate an early diagnosis to avoid structural damage to the joints.

-Able to identify the origin of the pain is essential in order to establish the most effective treatment and maintain the quality of life of the patient.

Madrid, January 2012.- The Association of sick ankylosing Parleños Associates (EDEPA) launches a campaign to raise awareness about chronic low back pain of inflammatory type, in order to help patients understand the characteristic symptoms of this type of pathology. As the central axis of the campaign, EDEPA presents www.siteduelelaespalda.com, a new space designed to raise awareness of the importance of treating lumbar pain and know distinguish if it is mechanical origin, i.e. the from, for example, bad postural habits or overwork of the lumbar region, or is inflammatory type that is associated with diseases such as ankylosing spondylitis.

Back pain in the lumbar region is one of the most common symptoms among adult in Spain and, according to data from the Spanish Rheumatology society (be), affects approximately 15% of the population. In this sense, to a correct approach to the same need to know tell whether low-back pain is mechanical or chronic inflammatory. Able to identify the origin is crucial to be able to establish the best therapeutic option, in order to maintain the quality of life of the patient and avoid failure that can cause these diseases.

For Miguel Ángel García, President of EDEPA, “ our goal is to help differentiate the characteristic symptoms of inflammatory back pain patients. While early symptoms are similar to low back pain, identify them correctly can help to make an early diagnosis and adequate treatment of the pathology, avoid structural damage and maintain the quality of life of patients ”.

Inflammatory chronic pain

Inflammatory chronic pain is characterized because the symptoms are alleviated with the exercise. Also, it is frequent to appear at night and usually manifested before age 40. Among the diseases that cause this type of pain is ankylosing spondylitis, according to the be affects the 1.2 and 1.9% of the population and, without proper treatment, can affect the mobility of the patient and cause inability. For its part, in low-back pain of mechanical origin, rest or with inadequate habits correction helps relieve the symptoms.

However, since the Association he emphasized the importance of consulting with a specialist to make the diagnosis and begin treatment at early stages of the disease. “ Web is a tool of information and help for the patient, but in no case replace the figure of the doctor ”, adds Miguel Ángel García.

Information about the back pain, in just one click

In this new space patients will find information about the different types of back pain, as well as useful tips developed by Arancha heir and Patricia Pérez, physiotherapists Association.

In addition, the recommendations include an exercise program, both in room and swimming pool, that patients can continue to complete their treatment, always under the supervision of a professional exercises to suit the specific characteristics of each patient.

The platform will also be included in the EDEPA (http://www.facebook.com/pages/Edepa-Dolor-Lumbar/323946170967096?sk=wall) facebook profile and allows patients to ask all your doubts and questions about the disease and the exercises.

About EDEPA

E.D.E.P.A is an apolitical and non-profit, association that has as main purpose meet, foster and promote spondylitis and arthritis patients in different social and labour activities and family. It leads to biological, clinical and epidemiological studies and related diseases, and maintains relations and contacts with centres and national and foreign institutions as regards médicos-tecnológicos advances in the treatment of these diseases.

Read More

1 in 3 women have given birth in the Hospital de La Ribera in 2011 donated blood from her umbilical cord to the Bank of the Valencian Community

|

1 of every 3 women have given birth in the Hospital de La Ribera in 2011 donated blood from the cord to the Banco de la Comunidad Valenciana

with about 800 units of blood, Alzira is the second Center of all the Valencian Community with the highest number of donations.

-La Ribera is integrated into the global network of umbilical cord blood banks and encourages the donation during pregnancy to inform the patient of the importance of this action altruistic.

-blood extracted from the umbilical cord is very valuable for the treatment of certain types of cancer and congenital diseases because it contains ‘ stem cell ’ specializing in the renovation of the cell blood.

-the collection does not imply ningcommon risk to the mother or the baby and takes place provided that the circumstances of childbirth are favourable and prior consent of the mother.

Alzira, January 2012- 1 of every 3 women have given birth at the Hospital Universitario de La Ribera in 2011 donated blood from her umbilical cord to the Valencian Community Blood Bank for further processing, storage and distribution to national and international health centres.

In this way, the Hospital of Alzira reached last year 760 blood donations among the more than 2,400 births attended, what has become the second throughout the Valencian Community in number of donations of umbilical cord blood to this health centre.

These data have been possible thanks to the solidarity of the patients and the active participation of the staff of La Ribera, which encourages the donation of blood during pregnancy and at the time of childbirth informing women of the importance of this altruistic action.

According to experts, the importance of these donations is that blood extracted from the umbilical cord is very valuable for the treatment of certain types of cancer and diseases of congenital character it contains ‘ stem cell ’ specialized in the renewal of the blood cells.

Hospital Universitario de La Ribera is integrated into the global network of umbilical cord blood banks. Through this agreement, La Ribera and the blood bank have protocolizados all the procedures to follow for the extraction of the blood and his subsequent transfer and treatment.

Use of umbilical cord blood

According to experts, the blood which is extracted from the umbilical cord is very cherished by the high number of stem cells (specializing in the renovation of the blood cells), capable of generating red blood cells (for transporting oxygen), WBCs (to defend against infectious agents) and platelets (which encourage clotting and prevent bleeding).

That is why this type of blood is essential in the treatment of certain diseases of congenital nature and specific types of cancers, including leukemia, both children and adults.

In these types of cancer, treatment obliges the administration of chemotherapy in very high doses, which eliminates both cancer cells and healthy cells, so it is needed infusion of stem cells to the patient regain the ability to produce new blood.

With cells from the umbilical cord blood is less likely a complication called graft disease versus host, in which the donor cells attack the tissues of the recipient.

This process does not imply any risk to the mother or the baby and takes place provided that the circumstances of childbirth are favourable and prior consent signed by the mother.

Read More

Red Asistencial Juaneda Consultes medical Juaneda Centre Centre opens

|

red Asistencial Juaneda Consultes medical Juaneda Centre Centre opens

-the new Center will encompass 9 clinics which will be attended by more than 30 professionals from 15 medical specialties

-centralizing these services in the new facility encourages the inclusion of new techniques and specialties, also facilitate comfort and improve the quality of treatment for patients

Palma de Mallorca, January 2012.- the Red Asistencial Juaneda group has taken a new step in the process of improving health care that currently provided in Palma de Mallorca with the implementation underway of a new Centre Consultes medical Juaneda Centre – located in Calle Jesús number 5 low – and in which more than 30 professionals respond to queries of the following medical specialties: cardiovascular surgery, general surgery, dermatology, Endocrinology, physiotherapy and rehabilitation medicine in general, internal medicine, Neurology, psychiatry, Radiology Imaging, manual therapy of the spine, trauma and orthopaedic surgery and Urology. addition of these specialties, the Centre will also feature extraction analysis clí servicesNicos (acupuntor doctor) acupuncture, osteopathy, Podiatry and psychology, as well as with medical care continued from 8.00 to 21.00 hours, without previous appointment.

The location of these services in the new facilities is a firm entity to offer maximum quality care and appropriate to the needs of patients, with first-level professionals, covering a large number of medical specialties and complement, where appropriate, consultation of hospitable character.

The central location of the new Center provides users access to these facilities also possessing a wide opening hours in order to provide the user the choice of the day and time of consultations and reducing in this way, the waiting times for patients. Thus, Consultes medical Juaneda Centre services will operate from Monday to Friday from 8.00 to 21.00 hours.

The implementation of the new Centre is due to the objective of responding adequately to the care demand in Mallorca and is part of the commitment of Red Asistencial Juaneda offer a healthcare integrated and based on the combination of three basic criteria: quality of service of diagnosis and medical care; maximum modernization and convenience facilities and exquisiteness in the treatment of human users.

Juaneda group is experiencing strong growth with the recent addition of a new hospital in Menorca (polyclinic Virgen de Gracia) in the beginning of 2012 and the opening of this new polyclinic in Palma de Mallorca, in addition to the expansion of its facilities in the complejo asistencial Juaneda clinic of almost 5,000 m2 which has scheduled end in the middle of this yearor and that being done jointly with Oftalmedic.

Red Asistencial Juaneda

Red Asistencial Juaneda is the leading hospital group in the Balearic Islands and one of the 15 first care groups nationally with sales planned for the 2011 more year of EUR 70 million. 3 Hospitals, 7 polyclinics and more than 30 medical centres, Red Asistencial Juaneda featuring assistance centers in the Canary Islands (clinic Scandinavica), the main network of dental centres in the Balearic Islands (Juaneda Dental), one of the leading companies in audits and food control has presence in the Balearic IslandsThe Canary Islands, Andalusia, Dominican Republic and Mexico (Saniconsult Ibérica, S.L.), a company of physiotherapy at home (Physio Domicili, s.l.) and a company of social services (Juaneda homeworkers, S.L.).

The healthcare group has experienced great growth in the past five years, having doubled its turnover and tripled the EBIDTA.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips